Gang Li

No ORCID on file · 6 papers in corpus · active 2012-2026

Study types

  • article 3
  • other 1

Condition tags

  • endometriosis 2
  • dysmenorrhea 1
  • adenomyosis 1
other 2026
Preliminary clinical observation on the treatment of adenomyosis by partial embolization of uterine artery with novel material combination: a case series
BMC women's health ·doi:10.1186/s12905-026-04313-5

OBJECTIVE: This study aims to investigate the efficacy of novel embolic materials in the treatment of adenomyosis via partial embolization of uterine arteries. METHODS: From June 2023 to June 2025, we used gelatin sponge particles, liquid s…

2024
Prenatal Exome Sequencing of Fetuses with Central Nervous System Anomalies Based on Prenatal Ultrasound and Magnetic Resonance Imaging Diagnosis — A Retrospective Cohort Study and System Review
·doi:10.21203/rs.3.rs-5459992/v1
2021
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
·doi:10.1101/2021.09.24.461616
article 2020
Propofol inhibits proliferation and invasion of endometriotic cells by miR-9-5p/TGFBI axis
·doi:10.1080/26895293.2020.1789761

Endometriosis (EM) is an estrogen-dependent, frequent benign gynecological disease, which reduces the quality of life in EM patients. Propofol regulates the apoptosis of EM. miR-9-5p is decreased in early secretory endometrium, TGFBI is inc…

article 2015
Notch Signaling Pathway Regulates Progesterone Secretion in Murine Luteal Cells
·doi:10.1177/1933719115572480
article 2012
Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice
Angiogenesis ·doi:10.1007/s10456-012-9299-4